Synthesis and antimicrobial testing of thiazolinyl-, thiazolidinonyl-quinoxalines and 1,2,4-triazolo[4,3-a]quinoxalines
Habib, N.S.; el-Hawash, S.A.
Die Pharmazie 52(8): 594-598
1997
ISSN/ISBN: 0031-7144 PMID: 9292917 Document Number: 469816
Three novel series of quinoxaline derivatives (thiazolinyl-, thiazolidinonyl-quinoxalines and 1,2,4-triazolo[4,3-a]quinoxalines) were synthesized. The results of in vitro antimicrobial studies demonstrated that the compounds showed antifungal activity against Candida albicans.
Document emailed within 1 workday
Related Documents
Schleinitz, K.D.; Westphal, G.; Köppel, H.; Wasicki, H. 1980: Potential virostatics. Part 3: NMR Studies in quinoxalines and s-triazolo (4,3-a) quinoxalines Die Pharmazie 35(2): 84-86Abbas, H.-A.S.; Al-Marhabi, A.R.M.; Ammar, Y.A. 2017: Design, Synthesis and Biological Evaluation of 2,3-Disubstituted and Fused Quinoxalines as Potential Anticancer and Antimicrobial Agents Acta Poloniae Pharmaceutica 74(2): 445-458
Loriga, M.; Moro, P.; Sanna, P.; Paglietti, G.; Zanetti, S. 1997: Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity Farmaco 52(8-9): 531-537
Kleckner, N.W.; Dingledine, R. 1989: Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors Molecular Pharmacology 36(3): 430-436
Varano, F.; Catarzi, D.; Colotta, V.; Cecchi, L.; Filacchioni, G.; Galli, A.; Costagli, C. 1997: Tricyclic heteroaromatic systems. 3-substituted 1,2,3,5,6,7-hexahydro-2,5,6-trioxopyrazino[1,2,3-de]-quinoxalines as novel antagonists at the glycine-NMDA site Farmaco 52(3): 179-182
Rinaldi, M.; Pecorari, P.; Costantino, L.; Provvisionato, A.; Malagoli, M.; Cermelli, C. 1992: Synthesis and biological activity of new heterocyclic structures: [1,3]thiazino[2,3-i]purine, thiazolo[3,2-c] [1,2,3]triazolo[4,5-e]pyrimidine and [1,2,3]triazolo [4', 5': 4,5] pyrimido[6,1-b][1,3]thiazine Farmaco 47(10): 1315-1322
Holla, B.S.; Shivananda, M.K.; Akberali, P.M.; Baliga, S.; Safeer, S. 1996: Studies on arylfuran derivatives-Part VI. Synthesis, characterization and antibacterial activities of some 6-(5-aryl-2-furyl)-1,2,4-triazolo [3,4-b]-1,3,4-thiadiazoles and 6-(5-nitro-2-furyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles Farmaco 51(12): 785-792
Hassan, E.; Al-Ashmawi, M.I.; Abd El-Fattah, B. 1983: Synthesis and antimicrobial testing of certain oxadiazoline and triazole derivatives Die Pharmazie 38(12): 833-835
Kandeel, E.M.; Hammouda, M.; Metwally, M.A. 1996: Aminoazoles in heterocyclic synthesis. Synthesis of some new pyrimidobenzimidazoles and pyrazolonopyridines as well as triazolo-, tetrazolo- and pyrazolo-pyrimidines of pharmaceutical interest Bollettino Chimico Farmaceutico 135(4): 232-235
Metwally, M.A.; el-Hossini, M.S.; el-Ablak, F.Z.; Khalil, A.M. 1992: Synthesis of condensed heterocycles from 3-aryl-2,4-dicarbethoxy-5-methylcyclohexanones and their testing for antimicrobial activity Die Pharmazie 47(5): 336-339
Guryn, R.; Szadowska, A.; Kiełek, M.B. 1988: Synthesis and pharmacologic properties of s-triazolo-1,4-diazepine derivatives Acta Poloniae Pharmaceutica 45(6): 512-516
Baraldi, P.G.; Cacciari, B.; Spalluto, G.; Pineda de las Infants, M.J.; Zocchi, C.; Ferrara, S.; Dionisotti, S.; FerraDDionisotti, S. 1996: 1,2,3-Triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: a new class of A2A adenosine receptor antagonists Farmaco 51(4): 297-300
Mazzone, G.; Bonina, F.; Pignatello, R.; Panico, A.M.; Caruso, A.; Leone, M.G.; Amico-Roxas, M.; Blandino, G. 1989: Carboxymethyl- and carboxy-derivatives of 7H- and 5H-1,2,4-triazolo [3,4-b][1,3,4] thiadiazine: synthesis and biological evaluation Farmaco 44(10): 933-944
Ali, K.A.; Ragab, E.A.; Farghaly, T.A.; Abdalla, M.M. 2011: Synthesis of new functionalized 3-substituted [1,2,4]triazolo [4,3-a]pyrimidine derivatives: potential antihypertensive agents Acta Poloniae Pharmaceutica 68(2): 237-247
Tarzia, G.; Occelli, E.; Barone, D. 1988: Benzodiazepine receptor ligands. Synthesis and pharmacological evaluation of 6-aryl-3,8-disubstituted-1,2,4-triazolo[3,4-a]phthalazines Il Farmaco; Edizione Scientifica 43(11): 921-933
Prescott, J.F.; Baggot, J.D. 1985: Antimicrobial susceptibility testing and antimicrobial drug dosage Journal of the American Veterinary Medical Association 187(4): 363-368
Delgado, F.; Pastor, J.; García-Navío, J.L.; Vaquero, J.J.; Alvarez-Builla, J.; Sunkel, C.; de Casa-Juana, M.F.; Priego, J.G.; Santos, L.R.; Statkow, P.R.; Straumann, D. 1997: Nonpeptide angiotensin Ii receptor antagonists: synthesis and biological activity of 1H-imidazo and 1H-[1,2,3]-triazolo fused derivatives Farmaco 52(3): 147-155
Tarzia, G.; Occelli, E.; Corsico, N.; Gallico, L.; Luzzani, F.; Barone, D. 1989: Benzodiazepine receptor ligands. Synthesis and preliminary pharmacological evaluation of 2-aminoalkyl-8-chloro- and 2-aryl-1,2,4-triazolo[3,4-a]phthalazine-3(2H)-ones Farmaco 44(1): 17-28
Schulz, U.; Freitag, M.; Schmidt, K.; Witetschek, M.; Polzin, M.; Morgenstern, O. 2014: Synthesis and structure elucidation of 2,3,5,6,7,8-hexahydro-1 H-[1,2,4]triazolo[1,2-a]pyridazine-1-thione, 3,3-disubstituted and 2-substituted derivatives and evaluation of their inhibitory activity against inducible nitric oxide synthase Die Pharmazie 69(10): 731-744
Schwarz, S.; Böttner, A.; Hafez, H.M.; Kehrenberg, C.; Kietzmann, M.; Klarmann, D.; Klein, Günter.; Krabisch, P.; Kühn, T.; Luhofer, G.; Richter, A.; Traeder, W.; Waldmann, K-Heinz.; Wallmann, Jürgen.; Werckenthin, C. 2003: Antimicrobial susceptibility testing of bacteria isolated from animals: methods for in-vitro susceptibility testing and their suitability with regard to the generation of the most useful data for therapeutic applications Berliner und Munchener Tierarztliche Wochenschrift 116(9-10): 353-361